Correlation Between MediciNova and Syros Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both MediciNova and Syros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Syros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Syros Pharmaceuticals, you can compare the effects of market volatilities on MediciNova and Syros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Syros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Syros Pharmaceuticals.
Diversification Opportunities for MediciNova and Syros Pharmaceuticals
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between MediciNova and Syros is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Syros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syros Pharmaceuticals and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Syros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syros Pharmaceuticals has no effect on the direction of MediciNova i.e., MediciNova and Syros Pharmaceuticals go up and down completely randomly.
Pair Corralation between MediciNova and Syros Pharmaceuticals
Given the investment horizon of 90 days MediciNova is expected to generate 0.49 times more return on investment than Syros Pharmaceuticals. However, MediciNova is 2.03 times less risky than Syros Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. Syros Pharmaceuticals is currently generating about -0.18 per unit of risk. If you would invest 168.00 in MediciNova on September 1, 2024 and sell it today you would earn a total of 39.00 from holding MediciNova or generate 23.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
MediciNova vs. Syros Pharmaceuticals
Performance |
| Timeline |
| MediciNova |
| Syros Pharmaceuticals |
MediciNova and Syros Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MediciNova and Syros Pharmaceuticals
The main advantage of trading using opposite MediciNova and Syros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Syros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syros Pharmaceuticals will offset losses from the drop in Syros Pharmaceuticals' long position.| MediciNova vs. Tff Pharmaceuticals | MediciNova vs. Eliem Therapeutics | MediciNova vs. Inhibrx | MediciNova vs. Enliven Therapeutics |
| Syros Pharmaceuticals vs. Tff Pharmaceuticals | Syros Pharmaceuticals vs. Eliem Therapeutics | Syros Pharmaceuticals vs. Inhibrx | Syros Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |